← ANALYST RATINGS · TIPRANKS
Pfizer (PFE): analyst forecast and price target
Price targets and ratings of
Analyst consensus
Moderate Buy8 Buy12 Hold0 Sell
Ratings of 20 analysts in the last 3 months · top analysts only12-month forecast
$30.04+1.6% upside
Based on 20 price targets given in the last 3 months, the average target is $30.04, the highest $36.00, the lowest $25.00. The average is +1.6% from the last price of $29.58.
Highest target $36.00
Average target $30.04
Lowest target $25.00
Analyst ratings 46
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Drug Manufacturers - GeneralxAI Grok-3 | TipRanks - xAI | $32.00 → $33.00+3.1% | Buy | +11.6% | Reiterated | 17.10.26on TipRanks Oct 16 23:05 | — | |
| AI DeepSeek Drug Manufacturers - GeneralDeepSeek R1-0528 | TipRanks - DeepSeek | $32.00 → $33.00+3.1% | Buy | +11.6% | Reiterated | 17.10.26on TipRanks Oct 16 23:05 | — | |
| AI OpenAI Drug Manufacturers - GeneralOpenAI 4o | TipRanks - OpenAI | $31.00 → $32.00+3.2% | Hold | +8.2% | Reiterated | 17.10.26on TipRanks Oct 16 23:05 | — | |
| AI Anthropic Drug Manufacturers - GeneralAnthropic Opus-4.1 | TipRanks - Anthropic | $29.00 → $30.00+3.4% | Hold | +1.4% | Reiterated | 17.10.26on TipRanks Oct 16 23:05 | — | |
| AI Google Drug Manufacturers - GeneralGemini 2.5Pro | TipRanks - Google | $32.00 → $33.00+3.1% | Buy | +11.6% | Reiterated | 17.10.26on TipRanks Oct 16 23:05 | — | |
| AI PerPlexity Drug Manufacturers - GeneralPerPlexity SonarPro | TipRanks - PerPlexity | $30.00 → $32.00+6.7% | Hold | +8.2% | Downgrade | 17.10.26on TipRanks Oct 16 23:05 | — | |
| Trung Huynh★★★★★★★★★★#475 · hits 76% · avg +21.9% | RBC Capital | $25.00 | Hold | −15.5% | Reiterated | 16.10.26on TipRanks 21:45 | after the close | ↗ |
| AI Anthropic Drug Manufacturers - GeneralAnthropic Opus-4.1 | TipRanks - Anthropic | $28.00 → $29.00+3.6% | Hold | −2.0% | Reiterated | 15.10.26on TipRanks Oct 14 23:05 | — | |
| AI xAi Drug Manufacturers - GeneralxAI Grok-3 | TipRanks - xAI | $31.00 → $32.00+3.2% | Buy | +8.2% | Reiterated | 13.10.26on TipRanks Oct 12 23:05 | — | |
| AI OpenAI Drug Manufacturers - GeneralOpenAI 4o | TipRanks - OpenAI | $30.00 → $31.00+3.3% | Hold | +4.8% | Reiterated | 13.10.26on TipRanks Oct 12 23:05 | — | |
| AI Google Drug Manufacturers - GeneralGemini 2.5Pro | TipRanks - Google | $31.00 → $32.00+3.2% | Buy | +8.2% | Reiterated | 13.10.26on TipRanks Oct 12 23:05 | — | |
| Vamil Divan★★★★★★★★★★#458 · hits 59% · avg +13.5% | Guggenheim | $31.00 | Buy | +4.8% | Reiterated | 12.10.26on TipRanks Oct 13 07:10 | +0.5%next day −0.1% | ↗ |
| Mohit Bansal★★★★★★★★★★#754 · hits 60% · avg +10.9% | Wells Fargo | $28.00 | Hold | −5.3% | Reiterated | 12.10.26on TipRanks Oct 13 05:30 | +0.5%next day −0.1% | ↗ |
| Evan Seigerman★★★★★★★★★★#856 · hits 59% · avg +9.3% | BMO Capital | $35.00 | Buy | +18.3% | Reiterated | 12.10.26on TipRanks 13:05 | +0.5%next day −0.1% | ↗ |
| Geoff Meacham★★★★★★★★★★#407 · hits 60% · avg +15.3% | Citi | $27.00 | Hold | −8.7% | Reiterated | 12.10.26on TipRanks 06:15 | +0.5%next day −0.1% | ↗ |
| Michael Yee★★★★★★★★★★#3077 · hits 49% · avg +3.8% | UBS | $27.00 | Hold | −8.7% | Reiterated | 09.10.26on TipRanks 09:15 | +1.1%next day +0.5% · 5 days +6.6% | ↗ |
| Chris Schott★★★★★★★★★★#1915 · hits 58% · avg +5.7% | J.P. Morgan | $28.00 → $30.00+7.1% | Hold | +1.4% | Assigned | 09.10.26on TipRanks 08:50 | +1.1%next day +0.5% · 5 days +6.6% | ↗ |
| Jason Gerberry★★★★★★★★★★#184 · hits 63% · avg +21.5% | Bank of America Securities | $27.00 → $29.00+7.4% | Hold | −2.0% | Reiterated | 09.10.26on TipRanks 06:55 | +1.1%next day +0.5% · 5 days +6.6% | ↗ |
| Trung Huynh★★★★★★★★★★#475 · hits 76% · avg +21.9% | RBC Capital | $25.00 | Hold | −15.5% | Reiterated | 08.10.26on TipRanks Oct 12 21:45 | −0.2%next day +1.1% · 5 days +6.1% | ↗ |
| Nico Chen★★★★★★★★★★#2913 · hits 59% · avg +9.8% | DBS | $35.00 | Buy | +18.3% | Reiterated | 08.10.26on TipRanks 14:05 | −0.2%next day +1.1% · 5 days +6.1% | ↗ |
| Akash Tewari★★★★★★★★★★#649 · hits 57% · avg +13.5% | Jefferies | $35.00 → $36.00+2.9% | Buy | +21.7% | Reiterated | 08.10.26on TipRanks 12:20 | −0.2%next day +1.1% · 5 days +6.1% | ↗ |
| Carter Gould★★★★★★★★★★#2194 · hits 53% · avg +6.3% | Cantor Fitzgerald | $27.00 → $28.00+3.7% | Hold | −5.3% | Assigned | 08.10.26on TipRanks 07:10 | −0.2%next day +1.1% · 5 days +6.1% | ↗ |
| Terence Flynn★★★★★★★★★★#815 · hits 60% · avg +10.8% | Morgan Stanley | $28.00 | Hold | −5.3% | Assigned | 07.10.26on TipRanks 08:15 | +2.1%next day −0.2% · 5 days +5.3% | ↗ |
| Luisa Hector★★★★★★★★★★#3558 · hits 58% · avg +4.9% | Berenberg Bank | $25.00 | Hold | −15.5% | Reiterated | 07.10.26on TipRanks 03:50 | +2.1%next day −0.2% · 5 days +5.3% | ↗ |
| Louise Chen★★★★★★★★★★#1899 · hits 52% · avg +5.9% | Scotiabank | $30.00 → $33.00+10.0% | Buy | +11.6% | Reiterated | 06.10.26on TipRanks 12:35 | −0.2%next day +2.1% · 5 days +3.3% | ↗ |
| AI xAi Drug Manufacturers - GeneralxAI Grok-3 | TipRanks - xAI | $32.00 → $31.00−3.1% | Buy | +4.8% | Reiterated | 03.10.26on TipRanks Oct 2 23:05 | — | |
| AI DeepSeek Drug Manufacturers - GeneralDeepSeek R1-0528 | TipRanks - DeepSeek | $33.00 → $32.00−3.0% | Buy | +8.2% | Reiterated | 03.10.26on TipRanks Oct 2 23:05 | — | |
| AI OpenAI Drug Manufacturers - GeneralOpenAI 4o | TipRanks - OpenAI | $31.00 → $30.00−3.2% | Hold | +1.4% | Reiterated | 03.10.26on TipRanks Oct 2 23:05 | — | |
| AI Anthropic Drug Manufacturers - GeneralAnthropic Opus-4.1 | TipRanks - Anthropic | $29.00 → $28.00−3.4% | Hold | −5.3% | Reiterated | 03.10.26on TipRanks Oct 2 23:05 | — | |
| AI Google Drug Manufacturers - GeneralGemini 2.5Pro | TipRanks - Google | $32.00 → $31.00−3.1% | Buy | +4.8% | Reiterated | 03.10.26on TipRanks Oct 2 23:05 | — | |
| AI PerPlexity Drug Manufacturers - GeneralPerPlexity SonarPro | TipRanks - PerPlexity | $31.00 → $30.00−3.2% | Hold | +1.4% | Downgrade | 03.10.26on TipRanks Oct 2 23:05 | — | |
| Geoff Meacham★★★★★★★★★★#407 · hits 60% · avg +15.3% | Citi | $27.00 | Hold | −8.7% | Reiterated | 02.10.26on TipRanks Oct 5 07:45 | −1.9%next day −2.1% · 5 days +0.6% | ↗ |
| Unknown Analyst | Leerink Partners | — | Hold | — | Reiterated | 02.10.26on TipRanks 08:50 | −1.9%next day −2.1% · 5 days +0.6% | ↗ |
| Louise Chen★★★★★★★★★★#1899 · hits 52% · avg +5.9% | Scotiabank | $30.00 | Buy | +1.4% | Reiterated | 02.10.26on TipRanks 07:25 | −1.9%next day −2.1% · 5 days +0.6% | ↗ |
| Akash Tewari★★★★★★★★★★#649 · hits 57% · avg +13.5% | Jefferies | $35.00 | Buy | +18.3% | Assigned | 02.10.26on TipRanks 03:50 | −1.9%next day −2.1% · 5 days +0.6% | ↗ |
| Michael Yee★★★★★★★★★★#3077 · hits 49% · avg +3.8% | UBS | $27.00 | Hold | −8.7% | Reiterated | 02.10.26on TipRanks 02:50 | −1.9%next day −2.1% · 5 days +0.6% | ↗ |
| AI xAi Drug Manufacturers - GeneralxAI Grok-3 | TipRanks - xAI | $32.00 | Buy | +8.2% | Reiterated | 01.10.26on TipRanks Sep 30 23:05 | — | |
| AI DeepSeek Drug Manufacturers - GeneralDeepSeek R1-0528 | TipRanks - DeepSeek | $33.00 | Buy | +11.6% | Reiterated | 01.10.26on TipRanks Sep 30 23:05 | — | |
| AI OpenAI Drug Manufacturers - GeneralOpenAI 4o | TipRanks - OpenAI | $31.00 | Hold | +4.8% | Reiterated | 01.10.26on TipRanks Sep 30 23:05 | — | |
| AI Anthropic Drug Manufacturers - GeneralAnthropic Opus-4.1 | TipRanks - Anthropic | $29.00 | Hold | −2.0% | Reiterated | 01.10.26on TipRanks Sep 30 23:05 | — | |
| AI Google Drug Manufacturers - GeneralGemini 2.5Pro | TipRanks - Google | $32.00 | Buy | +8.2% | Reiterated | 01.10.26on TipRanks Sep 30 23:05 | — | |
| AI PerPlexity Drug Manufacturers - GeneralPerPlexity SonarPro | TipRanks - PerPlexity | $31.00 | Hold | +4.8% | Downgrade | 01.10.26on TipRanks Sep 30 23:05 | — | |
| Chris Schott★★★★★★★★★★#1915 · hits 58% · avg +5.7% | J.P. Morgan | $28.00 | Hold | −5.3% | Reiterated | 25.09.26on TipRanks Sep 24 07:06 | +0.9%next day +0.4% · 5 days −0.6% | ↗ |
| Courtney Breen★★★★★★★★★★#1339 · hits 85% · avg +18.9% | Bernstein | $29.00 | Hold | −2.0% | Reiterated | 22.09.26on TipRanks Sep 23 06:15 | +0.7%next day +1.6% · 5 days +4.0% | ↗ |
| Trung Huynh★★★★★★★★★★#475 · hits 76% · avg +21.9% | RBC Capital | $25.00 | Hold | −15.5% | Reiterated | 21.09.26on TipRanks Sep 23 21:45 | −1.3%next day +0.7% · 5 days +4.6% | ↗ |
| Mohit Bansal★★★★★★★★★★#754 · hits 60% · avg +10.9% | Wells Fargo | $28.00 | Hold | −5.3% | Reiterated | 21.09.26on TipRanks Sep 22 06:10 | −1.3%next day +0.7% · 5 days +4.6% | ↗ |
| Rajesh Kumar★★★★★★★★★★#1587 · hits 62% · avg +14.5% | HSBC | $28.00 → $30.00+7.1% | Hold | +1.4% | Reiterated | 10.09.26on TipRanks 06:30 | +0.1%next day −0.6% · 5 days −0.7% | ↗ |
| Louise Chen★★★★★★★★★★#1899 · hits 52% · avg +5.9% | Scotiabank | $30.00 | Buy | +1.4% | Reiterated | 24.08.26on TipRanks 07:30 | −0.1%next day +1.8% · 5 days +1.3% | ↗ |
| Evan Seigerman★★★★★★★★★★#856 · hits 59% · avg +9.3% | BMO Capital | $30.00 | Buy | +1.4% | Reiterated | 17.08.26on TipRanks Aug 18 07:35 | +0.8%next day +2.1% · 5 days +5.3% | ↗ |
| Emily Field★★★★★★★★★★#5009 · hits 45% · avg +1.9% | Barclays | $25.00 | Sell | −15.5% | Reiterated | 13.08.26on TipRanks Aug 14 04:35 | +1.2%next day +0.2% · 5 days +5.7% | ↗ |
| Steve Scala★★★★★★★★★★#1275 · hits 63% · avg +10.5% | TD Cowen | — | Hold | — | Reiterated | 11.08.26on TipRanks Aug 12 02:30 | −1.3%next day −1.4% · 5 days +2.8% | ↗ |
| Jill Wu★★★★★★★★★★#513 · hits 52% · avg +26.4% | CMB International Securities | $35.46 → $35.75+0.8% | Buy | +20.9% | Reiterated | 07.08.26on TipRanks 12:30 | +1.5%next day +1.1% · 5 days −0.3% | ↗ |
| Vamil Divan★★★★★★★★★★#458 · hits 59% · avg +13.5% | Guggenheim | $35.00 → $31.00−11.4% | Buy | +4.8% | Reiterated | 06.08.26on TipRanks Aug 7 07:45 | +1.7%next day +1.5% · 5 days +1.1% | ↗ |
| Elmar Kraus★★★★★★★★★★#2504 · hits 70% · avg +9.8% | DZ BANK AG | — | Buy | — | Reiterated | 06.08.26on TipRanks 08:50 | +1.7%next day +1.5% · 5 days +1.1% | ↗ |
| David Toung★★★★★★★★★★#1098 · hits 63% · avg +9.1% | Argus Research | — | Buy | — | Reiterated | 05.08.26on TipRanks Aug 6 14:45 | +1.8%next day +1.7% · 5 days +1.6% | ↗ |
| Kerry Holford★★★★★★★★★★#2798 · hits 58% · avg +8.7% | Berenberg Bank | $25.00 | Hold | −15.5% | Reiterated | 05.08.26on TipRanks 08:50 | +1.8%next day +1.7% · 5 days +1.6% | ↗ |
| Geoff Meacham★★★★★★★★★★#407 · hits 60% · avg +15.3% | Citi | — | Hold | — | Reiterated | 05.08.26on TipRanks 06:40 | +1.8%next day +1.7% · 5 days +1.6% | ↗ |
| Akash Tewari★★★★★★★★★★#649 · hits 57% · avg +13.5% | Jefferies | $34.00 | Buy | +14.9% | Reiterated | 05.08.26on TipRanks 02:20 | +1.8%next day +1.7% · 5 days +1.6% | ↗ |
| Carter Gould★★★★★★★★★★#2194 · hits 53% · avg +6.3% | Cantor Fitzgerald | $27.00 | Hold | −8.7% | Reiterated | 04.08.26on TipRanks Aug 5 07:51 | −0.3%next day +1.8% · 5 days +4.9% | ↗ |
| Terence Flynn★★★★★★★★★★#815 · hits 60% · avg +10.8% | Morgan Stanley | $28.00 | Hold | −5.3% | Reiterated | 04.08.26on TipRanks Aug 5 07:50 | −0.3%next day +1.8% · 5 days +4.9% | ↗ |
| Asad Haider★★★★★★★★★★#1137 · hits 82% · avg +22.7% | Goldman Sachs | $26.00 | Hold | −12.1% | Reiterated | 04.08.26on TipRanks Aug 5 05:05 | −0.3%next day +1.8% · 5 days +4.9% | ↗ |
| Jason Gerberry★★★★★★★★★★#184 · hits 63% · avg +21.5% | Bank of America Securities | $26.00 → $27.00+3.8% | Hold | −8.7% | Reiterated | 04.08.26on TipRanks Aug 5 04:36 | −0.3%next day +1.8% · 5 days +4.9% | ↗ |
| Michael Yee★★★★★★★★★★#3077 · hits 49% · avg +3.8% | UBS | $27.00 | Hold | −8.7% | Reiterated | 23.06.26on TipRanks 02:50 | 0.0%next day −2.7% · 5 days −4.4% | ↗ |
| Alexandria Hammond★★★★★★★★★★#7870 · hits 50% · avg +0.6% | Wolfe Research | $25.00 → $26.00+4.0% | Sell | −12.1% | Reiterated | 13.05.26on TipRanks May 14 08:00 | −0.2%next day −1.6% · 5 days −0.5% | ↗ |
| Hans Engel★★★★★★★★★★#1835 · hits 58% · avg +11.1% | Erste Group | — | Hold | — | Reiterated | 05.05.26on TipRanks 07:00 | −0.2%next day −1.1% · 5 days −2.6% | ↗ |
| Umer Raffat★★★★★★★★★★#2336 · hits 50% · avg +9.4% | Evercore ISI | — | Buy | — | Reiterated | 27.04.26on TipRanks 09:15 | −1.0%next day −0.7% · 5 days −2.2% | ↗ |
| Narumi Nakagiri★★★★★★★★★★#5254 · hits 64% · avg +9.1% | Daiwa | $27.00 | Hold | −8.7% | Downgrade | 12.02.26on TipRanks 05:20 | +0.6%next day +0.3% · 5 days −4.2% | ↗ |
| David Risinger★★★★★★★★★★#64 · hits 65% · avg +33.1% | Leerink Partners | $26.00 | Hold | −12.1% | Reiterated | 09.12.25on TipRanks 10:50 | −1.6%next day +1.1% · 5 days +1.4% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering Pfizer
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $28.67 at a price of $28.52 (+0.5%); now: $29.62 at $29.58 (+0.1%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 21 | 21 | 20 | 20 | 14 | 16 |
| Hold | 31 | 40 | 36 | 36 | 25 | 27 |
| Sell | 3 | 3 | 1 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 03.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $0.73 (from $0.56 to $0.84). Last quarter: $0.77.
Sales
Next quarter’s sales estimate — $15.9B (from $14.7B to $16.9B). Last quarter: $15.0B.
Best top-analyst consensus in the sector · Healthcare
About Pfizer
- CEO: Albert Bourla
- Employees: 75,000
- 66 Hudson Boulevard East, New York City, NY, 10001-2192, US
- www.pfizer.com
Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, Pfizer provides sterile injectables, anti-infective agents, and a significant oral treatment for COVID-19, including Paxlovid. A substantial portion of its offerings comprises vaccines for infectious diseases such as pneumococcal and meningococcal disease, tick-borne encephalitis, and COVID-19, with notable products like Comirnaty and the Prevnar family. The firm also develops biosimilars for chronic autoimmune and inflammatory disorders, including Inflectra and Xeljanz, alongside specialized therapies for rare conditions like amyloidosis, hemophilia, and endocrine disorders, under brands such as Vyndaqel and BeneFIX. Beyond its proprietary products, Pfizer operates a contract manufacturing division. Its extensive customer base includes wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual medical practices, and public health organizations. The company actively fosters strategic collaborations with numerous partners, such as Bristol-Myers Squibb Company, BioNTech SE, and Merck KGaA. Established in 1849, Pfizer Inc. is headquartered in New York, New York.
Data from the stock’s TipRanks forecast page, read 18 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗